Literature DB >> 8381474

Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.

S Maurea1, A Cuocolo, J C Reynolds, S S Tumeh, M G Begley, W M Linehan, J A Norton, M M Walther, H R Keiser, R D Neumann.   

Abstract

Iodine-131-metaiodobenzylguanidine (MIBG) scintigraphy, transmission computed tomography and magnetic resonance imaging were used to evaluate 36 patients with clinically suspected functioning paragangliomas. The patients were divided into two groups. In Group 1 (n = 21), studied before surgery, patients mainly had benign adrenal disease. In Group 2 (n = 15), studied after surgery, patients frequently had malignant or extra-adrenal tumors. In Group 1, transmission computed tomography and magnetic resonance imaging were more sensitive (100% for both) than MIBG scintigraphy (82%), which, however, was the most specific (100%). In Group 2, MIBG scintigraphy and magnetic resonance imaging were more sensitive (83% for both) than transmission computed tomography (75%), but MIBG was again the most specific (100%). Thus, all three were complementary modalities for localizing paragangliomas both preoperatively and postoperatively. MIBG imaging is indicated for both groups but it is especially recommended for postsurgical patients with recurrence because the disease is often malignant or extra-adrenal.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381474

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Magnetic resonance imaging differentiation of adrenal masses at 1.5 T: T2-weighted images, chemical shift imaging, and Gd-DTPA dynamic studies.

Authors:  R Z Słapa; W Jakubowski; E Dabrowska; A Januszewicz; B Tymińska; T Feltynowski; M Lapiński; J Fijuth
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

2.  Detecting pheochromocytoma: defining the most sensitive test.

Authors:  Ulrich Guller; Joe Turek; Steve Eubanks; Elizabeth R Delong; Daniel Oertli; Jerome M Feldman
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

Review 3.  From Diagnosis to Therapy-PET Imaging for Pheochromocytomas and Paragangliomas.

Authors:  Hiren V Patel; Arnav Srivastava; Murray D Becker; Toni Beninato; Amanda M Laird; Eric A Singer
Journal:  Curr Urol Rep       Date:  2021-01-06       Impact factor: 3.092

Review 4.  ⁶⁸Ga-labelled peptides in the management of neuroectodermal tumours.

Authors:  Meeran Naji; Adil AL-Nahhas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 5.  The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.

Authors:  Alireza Mojtahedi; Sanjay Thamake; Izabela Tworowska; David Ranganathan; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

6.  Pheochromocytoma - update on disease management.

Authors:  Roland Därr; Jacques W M Lenders; Lorenz C Hofbauer; Bernd Naumann; Stefan R Bornstein; Graeme Eisenhofer
Journal:  Ther Adv Endocrinol Metab       Date:  2012-02       Impact factor: 3.565

Review 7.  Diagnosis and management of pheochromocytoma: a practical guide to clinicians.

Authors:  Joseph M Pappachan; Diana Raskauskiene; Rajagopalan Sriraman; Mahamood Edavalath; Fahmy W Hanna
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

8.  The usefulness of cardio-vascular visualization in the localization of mediastinal pheochromocytomas with I-131-MIBG.

Authors:  T Başoğlu; P Olivier; T Arsena; P Y Marie; J L Schlienger; G Karcher; A Bertrand
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

Review 9.  Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities.

Authors:  A P van Gils; A R van Erkel; T H Falke; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1994-03

10.  Successful outcome after resection of liver metastasis arising from an extraadrenal retroperitoneal paraganglioma that appeared 9 years after surgical excision of the primary lesion.

Authors:  Takehiro Noda; Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Masahiro Murakami; Shogo Kobayashi; Shigeru Marubashi; Yutaka Takeda; Keizo Dono; Koji Umeshita; Kenichi Wakasa; Morito Monden
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.